REGISTER for February 4 Webinar
I-Corps from the Trenches:
Conversation with Pilot Participants
1:00 PM EST
Apply through PA-16-019 by March 21, 2016
SBIR and STTR Phase I
grantees are invited to join the I-Corps™ at NIH program. Part of President Obama’s Strategy for American Innovation, I-Corps™ at NIH aims to support biomedical
innovation and translation, with the goal of expediting the development and
commercialization of technologies that address the leading causes of death and
disability in the United States. I-Corps™ participants will
receive capacity building and entrepreneurial training, mentorship
opportunities, and modest funding to assist in translating ideas from the lab
into a viable product on the market and help avoid common failure points.
For more information or questions on the I-Corps™ at NIH program, please visit http://sbir.cancer.gov/icorps/, watch
the archived webinar from November, or contact:
Jennifer C. Shieh, PhD, jennifer.shieh@nih.gov
Small Business Coordinator, Office of
Translational Alliances and Coordination, NHLBI
Submit
by February 5
The TechConnect World
& National Innovation Summit, and National SBIR/STTR Conference, will be
held May 23-25, 2016 at the Gaylord
National Convention Center in National Harbor, MD, adjacent to Washington DC.
For more information go to www.nationalsbirconference.com.
The TechConnect World & National
Innovation Summit offers a platform to help small firms present their
innovative technologies to potential corporate partners and funders. Top-ranked
innovations will be featured in the Innovation Summit program; all Innovation
Showcase technologies will be included in TechConnect's Corporate &
Investment Matching program.
Innovation Showcase for SBIR/STTR
Firms Seeking Partners: To be considered for this opportunity, submit a description
of your innovation online by Friday, February 5th at: http://bit.ly/TechConnect_Innovation_Challenge.
Check out the Corporate Acceleration Partners on the website as well.
A 10% showcase package discount is
available only to SBIR/STTR companies; this includes a 3-day registration for
both TechConnect World and the National SBIR/STTR Conference and a one day
booth space in the Innovation Showcase Expo. The registration also gives
access to the one-on-one SBIR/STTR meeting system. If you are interested
in this package, go online to submit your innovation by Feb. 5th and contact
Derek Mayer at 512.800.9796 or dmayer@techconnect.org
to receive the discounted showcase package rate.
REGISTER for
February 16 Webinar
Bioreactors
for Reparative Medicine
2:00 PM
EST
February 20 - Stem Cell-Derived Blood Products for Therapeutic Use:
Technology Improvement
SBIR: RFA-HL-15-030
For tools and technologies
that enable further advances in the manufacturing process to produce safe and
functional blood and platelet products at reduced costs.
Watch the December webinar recording: Stem Cell-Derived Blood Products
for Therapeutic Use: Technology Improvement
Questions?
Contact:
Shimian Zou, PhD, shimian.zou@nih.gov
Program Director, Division of Blood Diseases and Resources
John
Thomas, PhD, thomasj@nhlbi.nih.gov
Program Director, Division of Blood Diseases and Resources
April 14 - Bioreactors for Reparative Medicine
Learn more at the webinar on
February 16, 2 PM EST: Bioreactors for Reparative Medicine
SBIR HL-15-008;
SBIR Direct to Phase 2 HL-15-017; STTR HL-15-004
To support multidisciplinary small business teams in the
development of complex, three-dimensional engineering systems for growing
heart, lung, or bone marrow tissue.
The
next NIH Small Business Innovation Research (SBIR) and Small Business
Technology Transfer (STTR) Omnibus funding opportunity deadline is only a
couple months away on April 5, 2016. The National Heart, Lung, and Blood
Institute (NHLBI) welcomes all investigator-initiated projects within our mission through these funding opportunities:
For
Phase I, Phase II, and Fast-Track applications
Recent
clarification on eligibility criteria: NOT-OD-16-052
Learn about the NHLBI Mission
Additional
Funding Opportunities Due April 5, 2016
-
New Technologies for Viral Hepatitis (SBIR PA-15-077 STTR PA-15-076)
-
Safe and Effective Instruments and Devices
for Use in Neonatal and Pediatric Care Settings (SBIR PAR-13-090 STTR PAR-13-091)
-
For Phase II Awardees - Commercialization Readiness Pilot (CRP)
Program: Technical Assistance (SB1 PAR-16-026, Notice about NHLBI participation NOT-HL-15-283)
View all NHLBI targeted
funding opportunities
on our website (http://1.usa.gov/1LybmUa).
Get Ready
The mission of the Science Moving
towArds Research Translation and Therapy
(SMARTT) program is to accelerate translation of research from demonstration of
efficacy in vivo to submission of an investigational new drug application (IND)
to the FDA. To accomplish this, SMARTT has engaged highly qualified contractors
to provide regulatory affairs support, manufacturing, and
pharmacology/toxicology services to qualified projects.
Investigators who may be
considering submission of an application for SMARTT services are advised that
new requests will be accepted only until February 15, 2016.
Requests received after that date will not be evaluated until a future
application review cycle, most likely in the 3rd quarter of 2016.
Please visit the SMARTT website and
select the Critical Information and Application Guidance link
to learn more about the program. Select the “Submit SMARTT Application”
link on the home page to initiate a new request for services.
For more information, please
contact Ms. Sudie Rowshan, SMARTT Coordinating Center Project Director at srowshan@rti.org (919-541-8722).
2/8 - 2/9 – BIO
CEO & Investor Conference – New York City, NY
2/14 - 2/17 – AUTM 2016 Annual
Meeting – San Diego, CA
2/20 - 2/23 – Cardiovascular Research Technologies (CRT)
2016 – Washington, DC
3/9 – Boston Biotech Conferences – Boston, MA
5/23 – 5/25 – National SBIR/STTR Conference – National Harbor, MD
Save the Date! 11/15 – 11/17 - 18th
Annual HHS SBIR/STTR Conference – Orlando, FL
|
